A clinical phase II study with sorafenib in patients with progressive hormone-refractory prostate cancer: a study of the CESAR Central European Society for Anticancer Drug Research-EWIV.
Saved in:
| Title: | A clinical phase II study with sorafenib in patients with progressive hormone-refractory prostate cancer: a study of the CESAR Central European Society for Anticancer Drug Research-EWIV. |
|---|---|
| Authors: | Steinbild, S.1, Mros, K.1 mross@tumorbio.uni-freiburg.de, Frost, A.1, Morant, R.2, Gillessen, S.3, Dittrich, C.4, Strumberg, D.5, Hochhaus, A.6, Hanauske, A.-R.7, Edler, L.8, Burkholder, I.8, Scheulen, M.9, Mross, K (AUTHOR) |
| Source: | British Journal of Cancer. 12/3/2007, Vol. 97 Issue 11, p1480-1485. 6p. 3 Charts, 2 Graphs. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
